nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—ADRA2A—epilepsy syndrome	0.204	1	CbGaD
Tizanidine—multiple sclerosis—Diazepam—epilepsy syndrome	0.104	0.213	CpDpCtD
Tizanidine—multiple sclerosis—Oxcarbazepine—epilepsy syndrome	0.104	0.213	CpDpCtD
Tizanidine—multiple sclerosis—Pregabalin—epilepsy syndrome	0.0884	0.181	CpDpCtD
Tizanidine—multiple sclerosis—Carbamazepine—epilepsy syndrome	0.0788	0.161	CpDpCtD
Tizanidine—multiple sclerosis—Clonazepam—epilepsy syndrome	0.063	0.129	CpDpCtD
Tizanidine—multiple sclerosis—Gabapentin—epilepsy syndrome	0.0508	0.104	CpDpCtD
Tizanidine—CYP1A2—Carbamazepine—epilepsy syndrome	0.0176	0.203	CbGbCtD
Tizanidine—CYP1A2—Primidone—epilepsy syndrome	0.0164	0.19	CbGbCtD
Tizanidine—CYP1A2—Propofol—epilepsy syndrome	0.0147	0.17	CbGbCtD
Tizanidine—CYP1A2—Phenobarbital—epilepsy syndrome	0.014	0.162	CbGbCtD
Tizanidine—CYP1A2—Diazepam—epilepsy syndrome	0.0133	0.154	CbGbCtD
Tizanidine—CYP1A2—Valproic Acid—epilepsy syndrome	0.0105	0.121	CbGbCtD
Tizanidine—Brimonidine—ADRA2A—epilepsy syndrome	0.000722	0.364	CrCbGaD
Tizanidine—Apraclonidine—ADRA2A—epilepsy syndrome	0.000643	0.324	CrCbGaD
Tizanidine—Clonidine—ADRA2A—epilepsy syndrome	0.000322	0.163	CrCbGaD
Tizanidine—Clonidine—CYP2D6—epilepsy syndrome	0.000173	0.0871	CrCbGaD
Tizanidine—Clonidine—ABCB1—epilepsy syndrome	0.000123	0.0622	CrCbGaD
Tizanidine—Asthenia—Clonazepam—epilepsy syndrome	2.84e-05	0.000175	CcSEcCtD
Tizanidine—Rhinitis—Topiramate—epilepsy syndrome	2.84e-05	0.000175	CcSEcCtD
Tizanidine—Back pain—Gabapentin—epilepsy syndrome	2.83e-05	0.000175	CcSEcCtD
Tizanidine—Hepatitis—Topiramate—epilepsy syndrome	2.83e-05	0.000175	CcSEcCtD
Tizanidine—Haemorrhage—Topiramate—epilepsy syndrome	2.83e-05	0.000175	CcSEcCtD
Tizanidine—Nervous system disorder—Valproic Acid—epilepsy syndrome	2.83e-05	0.000175	CcSEcCtD
Tizanidine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	2.82e-05	0.000174	CcSEcCtD
Tizanidine—Asthenia—Phenytoin—epilepsy syndrome	2.82e-05	0.000174	CcSEcCtD
Tizanidine—Nausea—Midazolam—epilepsy syndrome	2.81e-05	0.000174	CcSEcCtD
Tizanidine—Hallucination—Topiramate—epilepsy syndrome	2.81e-05	0.000174	CcSEcCtD
Tizanidine—Muscle spasms—Gabapentin—epilepsy syndrome	2.81e-05	0.000174	CcSEcCtD
Tizanidine—Tachycardia—Valproic Acid—epilepsy syndrome	2.81e-05	0.000174	CcSEcCtD
Tizanidine—Diarrhoea—Zonisamide—epilepsy syndrome	2.81e-05	0.000174	CcSEcCtD
Tizanidine—Pharyngitis—Topiramate—epilepsy syndrome	2.81e-05	0.000174	CcSEcCtD
Tizanidine—Loss of consciousness—Pregabalin—epilepsy syndrome	2.81e-05	0.000173	CcSEcCtD
Tizanidine—Asthenia—Oxcarbazepine—epilepsy syndrome	2.81e-05	0.000173	CcSEcCtD
Tizanidine—Pruritus—Clonazepam—epilepsy syndrome	2.8e-05	0.000173	CcSEcCtD
Tizanidine—Vomiting—Vigabatrin—epilepsy syndrome	2.8e-05	0.000173	CcSEcCtD
Tizanidine—Skin disorder—Valproic Acid—epilepsy syndrome	2.8e-05	0.000173	CcSEcCtD
Tizanidine—Urinary tract disorder—Topiramate—epilepsy syndrome	2.79e-05	0.000173	CcSEcCtD
Tizanidine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	2.79e-05	0.000172	CcSEcCtD
Tizanidine—Pruritus—Phenytoin—epilepsy syndrome	2.78e-05	0.000172	CcSEcCtD
Tizanidine—Connective tissue disorder—Topiramate—epilepsy syndrome	2.78e-05	0.000172	CcSEcCtD
Tizanidine—Nausea—Levetiracetam—epilepsy syndrome	2.78e-05	0.000172	CcSEcCtD
Tizanidine—Rash—Vigabatrin—epilepsy syndrome	2.78e-05	0.000172	CcSEcCtD
Tizanidine—Dizziness—Felbamate—epilepsy syndrome	2.77e-05	0.000171	CcSEcCtD
Tizanidine—Dermatitis—Vigabatrin—epilepsy syndrome	2.77e-05	0.000171	CcSEcCtD
Tizanidine—Urethral disorder—Topiramate—epilepsy syndrome	2.77e-05	0.000171	CcSEcCtD
Tizanidine—Pruritus—Oxcarbazepine—epilepsy syndrome	2.77e-05	0.000171	CcSEcCtD
Tizanidine—Convulsion—Pregabalin—epilepsy syndrome	2.77e-05	0.000171	CcSEcCtD
Tizanidine—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.76e-05	0.000171	CcSEcCtD
Tizanidine—Vision blurred—Gabapentin—epilepsy syndrome	2.76e-05	0.00017	CcSEcCtD
Tizanidine—Hypertension—Pregabalin—epilepsy syndrome	2.76e-05	0.00017	CcSEcCtD
Tizanidine—Vomiting—Diazepam—epilepsy syndrome	2.76e-05	0.00017	CcSEcCtD
Tizanidine—Tremor—Gabapentin—epilepsy syndrome	2.74e-05	0.000169	CcSEcCtD
Tizanidine—Rash—Diazepam—epilepsy syndrome	2.73e-05	0.000169	CcSEcCtD
Tizanidine—Dermatitis—Diazepam—epilepsy syndrome	2.73e-05	0.000169	CcSEcCtD
Tizanidine—Arthralgia—Pregabalin—epilepsy syndrome	2.72e-05	0.000168	CcSEcCtD
Tizanidine—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.72e-05	0.000168	CcSEcCtD
Tizanidine—Dizziness—Zonisamide—epilepsy syndrome	2.72e-05	0.000168	CcSEcCtD
Tizanidine—Anxiety—Pregabalin—epilepsy syndrome	2.71e-05	0.000167	CcSEcCtD
Tizanidine—Diarrhoea—Clonazepam—epilepsy syndrome	2.71e-05	0.000167	CcSEcCtD
Tizanidine—Anaemia—Gabapentin—epilepsy syndrome	2.71e-05	0.000167	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.7e-05	0.000167	CcSEcCtD
Tizanidine—Hypotension—Valproic Acid—epilepsy syndrome	2.69e-05	0.000166	CcSEcCtD
Tizanidine—Asthenia—Carbamazepine—epilepsy syndrome	2.69e-05	0.000166	CcSEcCtD
Tizanidine—Agitation—Gabapentin—epilepsy syndrome	2.69e-05	0.000166	CcSEcCtD
Tizanidine—Diarrhoea—Phenytoin—epilepsy syndrome	2.69e-05	0.000166	CcSEcCtD
Tizanidine—Discomfort—Pregabalin—epilepsy syndrome	2.68e-05	0.000166	CcSEcCtD
Tizanidine—Nausea—Fosphenytoin—epilepsy syndrome	2.68e-05	0.000166	CcSEcCtD
Tizanidine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.68e-05	0.000165	CcSEcCtD
Tizanidine—Erythema multiforme—Topiramate—epilepsy syndrome	2.67e-05	0.000165	CcSEcCtD
Tizanidine—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.67e-05	0.000165	CcSEcCtD
Tizanidine—Vomiting—Felbamate—epilepsy syndrome	2.67e-05	0.000165	CcSEcCtD
Tizanidine—Dry mouth—Pregabalin—epilepsy syndrome	2.66e-05	0.000164	CcSEcCtD
Tizanidine—Pruritus—Carbamazepine—epilepsy syndrome	2.65e-05	0.000164	CcSEcCtD
Tizanidine—Rash—Felbamate—epilepsy syndrome	2.64e-05	0.000163	CcSEcCtD
Tizanidine—Dermatitis—Felbamate—epilepsy syndrome	2.64e-05	0.000163	CcSEcCtD
Tizanidine—Malaise—Gabapentin—epilepsy syndrome	2.64e-05	0.000163	CcSEcCtD
Tizanidine—Tinnitus—Topiramate—epilepsy syndrome	2.64e-05	0.000163	CcSEcCtD
Tizanidine—Vertigo—Gabapentin—epilepsy syndrome	2.63e-05	0.000163	CcSEcCtD
Tizanidine—Confusional state—Pregabalin—epilepsy syndrome	2.63e-05	0.000162	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.63e-05	0.000162	CcSEcCtD
Tizanidine—Cardiac disorder—Topiramate—epilepsy syndrome	2.63e-05	0.000162	CcSEcCtD
Tizanidine—Syncope—Gabapentin—epilepsy syndrome	2.62e-05	0.000162	CcSEcCtD
Tizanidine—Leukopenia—Gabapentin—epilepsy syndrome	2.62e-05	0.000162	CcSEcCtD
Tizanidine—Dizziness—Clonazepam—epilepsy syndrome	2.62e-05	0.000162	CcSEcCtD
Tizanidine—Nausea—Vigabatrin—epilepsy syndrome	2.61e-05	0.000162	CcSEcCtD
Tizanidine—Vomiting—Zonisamide—epilepsy syndrome	2.61e-05	0.000161	CcSEcCtD
Tizanidine—Oedema—Pregabalin—epilepsy syndrome	2.61e-05	0.000161	CcSEcCtD
Tizanidine—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.61e-05	0.000161	CcSEcCtD
Tizanidine—Asthenia—Lamotrigine—epilepsy syndrome	2.6e-05	0.000161	CcSEcCtD
Tizanidine—Dizziness—Phenytoin—epilepsy syndrome	2.6e-05	0.000161	CcSEcCtD
Tizanidine—Rash—Zonisamide—epilepsy syndrome	2.59e-05	0.00016	CcSEcCtD
Tizanidine—Infection—Pregabalin—epilepsy syndrome	2.59e-05	0.00016	CcSEcCtD
Tizanidine—Paraesthesia—Valproic Acid—epilepsy syndrome	2.59e-05	0.00016	CcSEcCtD
Tizanidine—Dermatitis—Zonisamide—epilepsy syndrome	2.59e-05	0.00016	CcSEcCtD
Tizanidine—Dizziness—Oxcarbazepine—epilepsy syndrome	2.59e-05	0.00016	CcSEcCtD
Tizanidine—Nausea—Diazepam—epilepsy syndrome	2.57e-05	0.000159	CcSEcCtD
Tizanidine—Loss of consciousness—Gabapentin—epilepsy syndrome	2.57e-05	0.000159	CcSEcCtD
Tizanidine—Dyspnoea—Valproic Acid—epilepsy syndrome	2.57e-05	0.000159	CcSEcCtD
Tizanidine—Diarrhoea—Carbamazepine—epilepsy syndrome	2.57e-05	0.000159	CcSEcCtD
Tizanidine—Angiopathy—Topiramate—epilepsy syndrome	2.57e-05	0.000159	CcSEcCtD
Tizanidine—Pruritus—Lamotrigine—epilepsy syndrome	2.57e-05	0.000159	CcSEcCtD
Tizanidine—Shock—Pregabalin—epilepsy syndrome	2.56e-05	0.000158	CcSEcCtD
Tizanidine—Somnolence—Valproic Acid—epilepsy syndrome	2.56e-05	0.000158	CcSEcCtD
Tizanidine—Immune system disorder—Topiramate—epilepsy syndrome	2.56e-05	0.000158	CcSEcCtD
Tizanidine—Nervous system disorder—Pregabalin—epilepsy syndrome	2.55e-05	0.000158	CcSEcCtD
Tizanidine—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.55e-05	0.000158	CcSEcCtD
Tizanidine—Mediastinal disorder—Topiramate—epilepsy syndrome	2.55e-05	0.000158	CcSEcCtD
Tizanidine—Tachycardia—Pregabalin—epilepsy syndrome	2.54e-05	0.000157	CcSEcCtD
Tizanidine—Dyspepsia—Valproic Acid—epilepsy syndrome	2.54e-05	0.000157	CcSEcCtD
Tizanidine—Convulsion—Gabapentin—epilepsy syndrome	2.54e-05	0.000157	CcSEcCtD
Tizanidine—Skin disorder—Pregabalin—epilepsy syndrome	2.53e-05	0.000156	CcSEcCtD
Tizanidine—Hypertension—Gabapentin—epilepsy syndrome	2.53e-05	0.000156	CcSEcCtD
Tizanidine—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.52e-05	0.000156	CcSEcCtD
Tizanidine—Vomiting—Clonazepam—epilepsy syndrome	2.52e-05	0.000156	CcSEcCtD
Tizanidine—Alopecia—Topiramate—epilepsy syndrome	2.5e-05	0.000155	CcSEcCtD
Tizanidine—Vomiting—Phenytoin—epilepsy syndrome	2.5e-05	0.000154	CcSEcCtD
Tizanidine—Rash—Clonazepam—epilepsy syndrome	2.5e-05	0.000154	CcSEcCtD
Tizanidine—Dermatitis—Clonazepam—epilepsy syndrome	2.49e-05	0.000154	CcSEcCtD
Tizanidine—Arthralgia—Gabapentin—epilepsy syndrome	2.49e-05	0.000154	CcSEcCtD
Tizanidine—Nausea—Felbamate—epilepsy syndrome	2.49e-05	0.000154	CcSEcCtD
Tizanidine—Vomiting—Oxcarbazepine—epilepsy syndrome	2.49e-05	0.000154	CcSEcCtD
Tizanidine—Fatigue—Valproic Acid—epilepsy syndrome	2.48e-05	0.000154	CcSEcCtD
Tizanidine—Anxiety—Gabapentin—epilepsy syndrome	2.48e-05	0.000153	CcSEcCtD
Tizanidine—Dizziness—Carbamazepine—epilepsy syndrome	2.48e-05	0.000153	CcSEcCtD
Tizanidine—Diarrhoea—Lamotrigine—epilepsy syndrome	2.48e-05	0.000153	CcSEcCtD
Tizanidine—Rash—Phenytoin—epilepsy syndrome	2.48e-05	0.000153	CcSEcCtD
Tizanidine—Mental disorder—Topiramate—epilepsy syndrome	2.48e-05	0.000153	CcSEcCtD
Tizanidine—Dermatitis—Phenytoin—epilepsy syndrome	2.48e-05	0.000153	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.47e-05	0.000153	CcSEcCtD
Tizanidine—Rash—Oxcarbazepine—epilepsy syndrome	2.47e-05	0.000152	CcSEcCtD
Tizanidine—Constipation—Valproic Acid—epilepsy syndrome	2.46e-05	0.000152	CcSEcCtD
Tizanidine—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.46e-05	0.000152	CcSEcCtD
Tizanidine—Discomfort—Gabapentin—epilepsy syndrome	2.46e-05	0.000152	CcSEcCtD
Tizanidine—Nausea—Zonisamide—epilepsy syndrome	2.44e-05	0.000151	CcSEcCtD
Tizanidine—Dry mouth—Gabapentin—epilepsy syndrome	2.44e-05	0.000151	CcSEcCtD
Tizanidine—Hypotension—Pregabalin—epilepsy syndrome	2.43e-05	0.00015	CcSEcCtD
Tizanidine—Flatulence—Topiramate—epilepsy syndrome	2.43e-05	0.00015	CcSEcCtD
Tizanidine—Tension—Topiramate—epilepsy syndrome	2.42e-05	0.000149	CcSEcCtD
Tizanidine—Confusional state—Gabapentin—epilepsy syndrome	2.41e-05	0.000149	CcSEcCtD
Tizanidine—Dizziness—Lamotrigine—epilepsy syndrome	2.4e-05	0.000148	CcSEcCtD
Tizanidine—Nervousness—Topiramate—epilepsy syndrome	2.39e-05	0.000148	CcSEcCtD
Tizanidine—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.39e-05	0.000148	CcSEcCtD
Tizanidine—Oedema—Gabapentin—epilepsy syndrome	2.39e-05	0.000148	CcSEcCtD
Tizanidine—Vomiting—Carbamazepine—epilepsy syndrome	2.39e-05	0.000147	CcSEcCtD
Tizanidine—Back pain—Topiramate—epilepsy syndrome	2.38e-05	0.000147	CcSEcCtD
Tizanidine—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.37e-05	0.000147	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.37e-05	0.000147	CcSEcCtD
Tizanidine—Infection—Gabapentin—epilepsy syndrome	2.37e-05	0.000147	CcSEcCtD
Tizanidine—Muscle spasms—Topiramate—epilepsy syndrome	2.37e-05	0.000146	CcSEcCtD
Tizanidine—Rash—Carbamazepine—epilepsy syndrome	2.37e-05	0.000146	CcSEcCtD
Tizanidine—Dermatitis—Carbamazepine—epilepsy syndrome	2.36e-05	0.000146	CcSEcCtD
Tizanidine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.36e-05	0.000146	CcSEcCtD
Tizanidine—Nausea—Clonazepam—epilepsy syndrome	2.35e-05	0.000145	CcSEcCtD
Tizanidine—Shock—Gabapentin—epilepsy syndrome	2.35e-05	0.000145	CcSEcCtD
Tizanidine—Nervous system disorder—Gabapentin—epilepsy syndrome	2.34e-05	0.000145	CcSEcCtD
Tizanidine—Paraesthesia—Pregabalin—epilepsy syndrome	2.34e-05	0.000145	CcSEcCtD
Tizanidine—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.34e-05	0.000145	CcSEcCtD
Tizanidine—Nausea—Phenytoin—epilepsy syndrome	2.33e-05	0.000144	CcSEcCtD
Tizanidine—Tachycardia—Gabapentin—epilepsy syndrome	2.33e-05	0.000144	CcSEcCtD
Tizanidine—Dyspnoea—Pregabalin—epilepsy syndrome	2.32e-05	0.000144	CcSEcCtD
Tizanidine—Nausea—Oxcarbazepine—epilepsy syndrome	2.32e-05	0.000144	CcSEcCtD
Tizanidine—Vision blurred—Topiramate—epilepsy syndrome	2.32e-05	0.000143	CcSEcCtD
Tizanidine—Skin disorder—Gabapentin—epilepsy syndrome	2.32e-05	0.000143	CcSEcCtD
Tizanidine—Somnolence—Pregabalin—epilepsy syndrome	2.32e-05	0.000143	CcSEcCtD
Tizanidine—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.31e-05	0.000143	CcSEcCtD
Tizanidine—Tremor—Topiramate—epilepsy syndrome	2.31e-05	0.000143	CcSEcCtD
Tizanidine—Vomiting—Lamotrigine—epilepsy syndrome	2.31e-05	0.000143	CcSEcCtD
Tizanidine—Urticaria—Valproic Acid—epilepsy syndrome	2.29e-05	0.000141	CcSEcCtD
Tizanidine—Rash—Lamotrigine—epilepsy syndrome	2.29e-05	0.000141	CcSEcCtD
Tizanidine—Ill-defined disorder—Topiramate—epilepsy syndrome	2.28e-05	0.000141	CcSEcCtD
Tizanidine—Dermatitis—Lamotrigine—epilepsy syndrome	2.28e-05	0.000141	CcSEcCtD
Tizanidine—Body temperature increased—Valproic Acid—epilepsy syndrome	2.28e-05	0.000141	CcSEcCtD
Tizanidine—Abdominal pain—Valproic Acid—epilepsy syndrome	2.28e-05	0.000141	CcSEcCtD
Tizanidine—Anaemia—Topiramate—epilepsy syndrome	2.28e-05	0.000141	CcSEcCtD
Tizanidine—Agitation—Topiramate—epilepsy syndrome	2.26e-05	0.00014	CcSEcCtD
Tizanidine—Fatigue—Pregabalin—epilepsy syndrome	2.25e-05	0.000139	CcSEcCtD
Tizanidine—Hypotension—Gabapentin—epilepsy syndrome	2.23e-05	0.000138	CcSEcCtD
Tizanidine—Nausea—Carbamazepine—epilepsy syndrome	2.23e-05	0.000138	CcSEcCtD
Tizanidine—Constipation—Pregabalin—epilepsy syndrome	2.23e-05	0.000138	CcSEcCtD
Tizanidine—Malaise—Topiramate—epilepsy syndrome	2.22e-05	0.000137	CcSEcCtD
Tizanidine—Vertigo—Topiramate—epilepsy syndrome	2.21e-05	0.000137	CcSEcCtD
Tizanidine—Syncope—Topiramate—epilepsy syndrome	2.21e-05	0.000136	CcSEcCtD
Tizanidine—Leukopenia—Topiramate—epilepsy syndrome	2.2e-05	0.000136	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.18e-05	0.000135	CcSEcCtD
Tizanidine—Loss of consciousness—Topiramate—epilepsy syndrome	2.16e-05	0.000134	CcSEcCtD
Tizanidine—Nausea—Lamotrigine—epilepsy syndrome	2.15e-05	0.000133	CcSEcCtD
Tizanidine—Feeling abnormal—Pregabalin—epilepsy syndrome	2.15e-05	0.000133	CcSEcCtD
Tizanidine—Paraesthesia—Gabapentin—epilepsy syndrome	2.15e-05	0.000133	CcSEcCtD
Tizanidine—Convulsion—Topiramate—epilepsy syndrome	2.13e-05	0.000132	CcSEcCtD
Tizanidine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.13e-05	0.000132	CcSEcCtD
Tizanidine—Dyspnoea—Gabapentin—epilepsy syndrome	2.13e-05	0.000132	CcSEcCtD
Tizanidine—Hypertension—Topiramate—epilepsy syndrome	2.13e-05	0.000131	CcSEcCtD
Tizanidine—Somnolence—Gabapentin—epilepsy syndrome	2.12e-05	0.000131	CcSEcCtD
Tizanidine—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.12e-05	0.000131	CcSEcCtD
Tizanidine—Dyspepsia—Gabapentin—epilepsy syndrome	2.1e-05	0.00013	CcSEcCtD
Tizanidine—Arthralgia—Topiramate—epilepsy syndrome	2.1e-05	0.00013	CcSEcCtD
Tizanidine—Anxiety—Topiramate—epilepsy syndrome	2.09e-05	0.000129	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.08e-05	0.000129	CcSEcCtD
Tizanidine—Discomfort—Topiramate—epilepsy syndrome	2.07e-05	0.000128	CcSEcCtD
Tizanidine—Urticaria—Pregabalin—epilepsy syndrome	2.07e-05	0.000128	CcSEcCtD
Tizanidine—Asthenia—Valproic Acid—epilepsy syndrome	2.07e-05	0.000128	CcSEcCtD
Tizanidine—Fatigue—Gabapentin—epilepsy syndrome	2.06e-05	0.000127	CcSEcCtD
Tizanidine—Body temperature increased—Pregabalin—epilepsy syndrome	2.06e-05	0.000127	CcSEcCtD
Tizanidine—Abdominal pain—Pregabalin—epilepsy syndrome	2.06e-05	0.000127	CcSEcCtD
Tizanidine—Dry mouth—Topiramate—epilepsy syndrome	2.05e-05	0.000127	CcSEcCtD
Tizanidine—Constipation—Gabapentin—epilepsy syndrome	2.04e-05	0.000126	CcSEcCtD
Tizanidine—Pruritus—Valproic Acid—epilepsy syndrome	2.04e-05	0.000126	CcSEcCtD
Tizanidine—Confusional state—Topiramate—epilepsy syndrome	2.03e-05	0.000125	CcSEcCtD
Tizanidine—Oedema—Topiramate—epilepsy syndrome	2.01e-05	0.000124	CcSEcCtD
Tizanidine—Infection—Topiramate—epilepsy syndrome	2e-05	0.000123	CcSEcCtD
Tizanidine—Shock—Topiramate—epilepsy syndrome	1.98e-05	0.000122	CcSEcCtD
Tizanidine—Diarrhoea—Valproic Acid—epilepsy syndrome	1.97e-05	0.000122	CcSEcCtD
Tizanidine—Nervous system disorder—Topiramate—epilepsy syndrome	1.97e-05	0.000122	CcSEcCtD
Tizanidine—Feeling abnormal—Gabapentin—epilepsy syndrome	1.97e-05	0.000122	CcSEcCtD
Tizanidine—Thrombocytopenia—Topiramate—epilepsy syndrome	1.97e-05	0.000122	CcSEcCtD
Tizanidine—Tachycardia—Topiramate—epilepsy syndrome	1.96e-05	0.000121	CcSEcCtD
Tizanidine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.95e-05	0.000121	CcSEcCtD
Tizanidine—Skin disorder—Topiramate—epilepsy syndrome	1.95e-05	0.000121	CcSEcCtD
Tizanidine—Hyperhidrosis—Topiramate—epilepsy syndrome	1.94e-05	0.00012	CcSEcCtD
Tizanidine—Hypersensitivity—Pregabalin—epilepsy syndrome	1.92e-05	0.000119	CcSEcCtD
Tizanidine—Dizziness—Valproic Acid—epilepsy syndrome	1.91e-05	0.000118	CcSEcCtD
Tizanidine—Urticaria—Gabapentin—epilepsy syndrome	1.9e-05	0.000117	CcSEcCtD
Tizanidine—Abdominal pain—Gabapentin—epilepsy syndrome	1.89e-05	0.000117	CcSEcCtD
Tizanidine—Body temperature increased—Gabapentin—epilepsy syndrome	1.89e-05	0.000117	CcSEcCtD
Tizanidine—Hypotension—Topiramate—epilepsy syndrome	1.88e-05	0.000116	CcSEcCtD
Tizanidine—Asthenia—Pregabalin—epilepsy syndrome	1.87e-05	0.000116	CcSEcCtD
Tizanidine—Pruritus—Pregabalin—epilepsy syndrome	1.84e-05	0.000114	CcSEcCtD
Tizanidine—Vomiting—Valproic Acid—epilepsy syndrome	1.83e-05	0.000113	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.83e-05	0.000113	CcSEcCtD
Tizanidine—Rash—Valproic Acid—epilepsy syndrome	1.82e-05	0.000112	CcSEcCtD
Tizanidine—Dermatitis—Valproic Acid—epilepsy syndrome	1.82e-05	0.000112	CcSEcCtD
Tizanidine—Paraesthesia—Topiramate—epilepsy syndrome	1.8e-05	0.000112	CcSEcCtD
Tizanidine—Dyspnoea—Topiramate—epilepsy syndrome	1.79e-05	0.000111	CcSEcCtD
Tizanidine—Somnolence—Topiramate—epilepsy syndrome	1.79e-05	0.00011	CcSEcCtD
Tizanidine—Diarrhoea—Pregabalin—epilepsy syndrome	1.78e-05	0.00011	CcSEcCtD
Tizanidine—Dyspepsia—Topiramate—epilepsy syndrome	1.77e-05	0.000109	CcSEcCtD
Tizanidine—Hypersensitivity—Gabapentin—epilepsy syndrome	1.76e-05	0.000109	CcSEcCtD
Tizanidine—Fatigue—Topiramate—epilepsy syndrome	1.73e-05	0.000107	CcSEcCtD
Tizanidine—Dizziness—Pregabalin—epilepsy syndrome	1.72e-05	0.000106	CcSEcCtD
Tizanidine—Constipation—Topiramate—epilepsy syndrome	1.72e-05	0.000106	CcSEcCtD
Tizanidine—Asthenia—Gabapentin—epilepsy syndrome	1.71e-05	0.000106	CcSEcCtD
Tizanidine—Nausea—Valproic Acid—epilepsy syndrome	1.71e-05	0.000106	CcSEcCtD
Tizanidine—Pruritus—Gabapentin—epilepsy syndrome	1.69e-05	0.000104	CcSEcCtD
Tizanidine—Vomiting—Pregabalin—epilepsy syndrome	1.66e-05	0.000102	CcSEcCtD
Tizanidine—Feeling abnormal—Topiramate—epilepsy syndrome	1.66e-05	0.000102	CcSEcCtD
Tizanidine—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.64e-05	0.000102	CcSEcCtD
Tizanidine—Rash—Pregabalin—epilepsy syndrome	1.64e-05	0.000102	CcSEcCtD
Tizanidine—Dermatitis—Pregabalin—epilepsy syndrome	1.64e-05	0.000101	CcSEcCtD
Tizanidine—Diarrhoea—Gabapentin—epilepsy syndrome	1.63e-05	0.000101	CcSEcCtD
Tizanidine—Urticaria—Topiramate—epilepsy syndrome	1.6e-05	9.87e-05	CcSEcCtD
Tizanidine—Abdominal pain—Topiramate—epilepsy syndrome	1.59e-05	9.82e-05	CcSEcCtD
Tizanidine—Body temperature increased—Topiramate—epilepsy syndrome	1.59e-05	9.82e-05	CcSEcCtD
Tizanidine—Dizziness—Gabapentin—epilepsy syndrome	1.58e-05	9.76e-05	CcSEcCtD
Tizanidine—Nausea—Pregabalin—epilepsy syndrome	1.55e-05	9.56e-05	CcSEcCtD
Tizanidine—Vomiting—Gabapentin—epilepsy syndrome	1.52e-05	9.39e-05	CcSEcCtD
Tizanidine—Rash—Gabapentin—epilepsy syndrome	1.51e-05	9.31e-05	CcSEcCtD
Tizanidine—Dermatitis—Gabapentin—epilepsy syndrome	1.5e-05	9.3e-05	CcSEcCtD
Tizanidine—Hypersensitivity—Topiramate—epilepsy syndrome	1.48e-05	9.15e-05	CcSEcCtD
Tizanidine—Asthenia—Topiramate—epilepsy syndrome	1.44e-05	8.91e-05	CcSEcCtD
Tizanidine—Pruritus—Topiramate—epilepsy syndrome	1.42e-05	8.79e-05	CcSEcCtD
Tizanidine—Nausea—Gabapentin—epilepsy syndrome	1.42e-05	8.77e-05	CcSEcCtD
Tizanidine—Diarrhoea—Topiramate—epilepsy syndrome	1.38e-05	8.5e-05	CcSEcCtD
Tizanidine—Dizziness—Topiramate—epilepsy syndrome	1.33e-05	8.21e-05	CcSEcCtD
Tizanidine—Vomiting—Topiramate—epilepsy syndrome	1.28e-05	7.9e-05	CcSEcCtD
Tizanidine—Rash—Topiramate—epilepsy syndrome	1.27e-05	7.83e-05	CcSEcCtD
Tizanidine—Dermatitis—Topiramate—epilepsy syndrome	1.27e-05	7.82e-05	CcSEcCtD
Tizanidine—Nausea—Topiramate—epilepsy syndrome	1.19e-05	7.38e-05	CcSEcCtD
Tizanidine—ADRA2A—Signaling Pathways—GABBR1—epilepsy syndrome	6.42e-06	0.000113	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCR2—epilepsy syndrome	6.41e-06	0.000112	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SST—epilepsy syndrome	6.41e-06	0.000112	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NTRK2—epilepsy syndrome	6.41e-06	0.000112	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NT5E—epilepsy syndrome	6.41e-06	0.000112	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALAD—epilepsy syndrome	6.41e-06	0.000112	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—HTR2A—epilepsy syndrome	6.39e-06	0.000112	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—DUSP6—epilepsy syndrome	6.36e-06	0.000112	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ADRA2A—epilepsy syndrome	6.27e-06	0.00011	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PLAT—epilepsy syndrome	6.25e-06	0.00011	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AVP—epilepsy syndrome	6.24e-06	0.00011	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PRKCB—epilepsy syndrome	6.17e-06	0.000108	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PTK2B—epilepsy syndrome	6.16e-06	0.000108	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TSC1—epilepsy syndrome	6.16e-06	0.000108	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HRH3—epilepsy syndrome	6.15e-06	0.000108	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—SRC—epilepsy syndrome	6.14e-06	0.000108	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	6.11e-06	0.000107	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	6.11e-06	0.000107	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—AGT—epilepsy syndrome	6.07e-06	0.000106	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—OPRM1—epilepsy syndrome	6.06e-06	0.000106	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—BDKRB2—epilepsy syndrome	6.03e-06	0.000106	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CXCL12—epilepsy syndrome	6.03e-06	0.000106	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—POMC—epilepsy syndrome	6.02e-06	0.000106	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PRKCB—epilepsy syndrome	6e-06	0.000105	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NTRK2—epilepsy syndrome	5.99e-06	0.000105	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCR2—epilepsy syndrome	5.99e-06	0.000105	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SST—epilepsy syndrome	5.99e-06	0.000105	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—VEGFA—epilepsy syndrome	5.98e-06	0.000105	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	5.98e-06	0.000105	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP2D6—epilepsy syndrome	5.98e-06	0.000105	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL6ST—epilepsy syndrome	5.98e-06	0.000105	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—DUSP6—epilepsy syndrome	5.94e-06	0.000104	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CNR1—epilepsy syndrome	5.92e-06	0.000104	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—JUNB—epilepsy syndrome	5.92e-06	0.000104	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PLCB1—epilepsy syndrome	5.9e-06	0.000103	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ADSL—epilepsy syndrome	5.86e-06	0.000103	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ADRA2A—epilepsy syndrome	5.86e-06	0.000103	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CCR5—epilepsy syndrome	5.84e-06	0.000103	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PLAT—epilepsy syndrome	5.84e-06	0.000102	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HTR7—epilepsy syndrome	5.77e-06	0.000101	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GLUL—epilepsy syndrome	5.75e-06	0.000101	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—SRC—epilepsy syndrome	5.74e-06	0.000101	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCR3—epilepsy syndrome	5.72e-06	0.0001	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—HTR2A—epilepsy syndrome	5.72e-06	0.0001	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—BCHE—epilepsy syndrome	5.67e-06	9.95e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	5.64e-06	9.9e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—BDKRB2—epilepsy syndrome	5.63e-06	9.88e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CXCL12—epilepsy syndrome	5.63e-06	9.88e-05	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—POMC—epilepsy syndrome	5.62e-06	9.87e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	5.62e-06	9.86e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PRKCB—epilepsy syndrome	5.61e-06	9.83e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HBEGF—epilepsy syndrome	5.6e-06	9.83e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—VEGFA—epilepsy syndrome	5.59e-06	9.81e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL6ST—epilepsy syndrome	5.58e-06	9.8e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NPY—epilepsy syndrome	5.58e-06	9.78e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ATP2A2—epilepsy syndrome	5.58e-06	9.78e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—JUNB—epilepsy syndrome	5.53e-06	9.7e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CNR1—epilepsy syndrome	5.53e-06	9.7e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PLCB1—epilepsy syndrome	5.51e-06	9.66e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKT3—epilepsy syndrome	5.5e-06	9.65e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—HMOX1—epilepsy syndrome	5.48e-06	9.61e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—POMC—epilepsy syndrome	5.47e-06	9.59e-05	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AGT—epilepsy syndrome	5.43e-06	9.52e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—SLC2A1—epilepsy syndrome	5.41e-06	9.49e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CAT—epilepsy syndrome	5.4e-06	9.48e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HTR7—epilepsy syndrome	5.39e-06	9.46e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCL2—epilepsy syndrome	5.38e-06	9.44e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HSPB1—epilepsy syndrome	5.38e-06	9.44e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCL3—epilepsy syndrome	5.38e-06	9.44e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—OXT—epilepsy syndrome	5.38e-06	9.44e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CRH—epilepsy syndrome	5.38e-06	9.44e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ADAM10—epilepsy syndrome	5.37e-06	9.43e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PLCB1—epilepsy syndrome	5.35e-06	9.39e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CCL2—epilepsy syndrome	5.35e-06	9.38e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—TH—epilepsy syndrome	5.33e-06	9.35e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CCR5—epilepsy syndrome	5.31e-06	9.31e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	5.28e-06	9.26e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ABCB1—epilepsy syndrome	5.26e-06	9.22e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HBEGF—epilepsy syndrome	5.23e-06	9.19e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—HTR2A—epilepsy syndrome	5.19e-06	9.11e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKT3—epilepsy syndrome	5.14e-06	9.02e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AQP1—epilepsy syndrome	5.12e-06	8.99e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—POMC—epilepsy syndrome	5.11e-06	8.96e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—S100B—epilepsy syndrome	5.08e-06	8.91e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SOCS3—epilepsy syndrome	5.03e-06	8.83e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CDC42—epilepsy syndrome	5.02e-06	8.81e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ADAM10—epilepsy syndrome	5.02e-06	8.81e-05	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.01e-06	8.8e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PTK2B—epilepsy syndrome	5e-06	8.77e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TSC1—epilepsy syndrome	5e-06	8.77e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CCL2—epilepsy syndrome	5e-06	8.77e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AGT—epilepsy syndrome	4.93e-06	8.65e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.92e-06	8.63e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GPX1—epilepsy syndrome	4.89e-06	8.58e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCR2—epilepsy syndrome	4.86e-06	8.54e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SST—epilepsy syndrome	4.86e-06	8.54e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NTRK2—epilepsy syndrome	4.86e-06	8.54e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AVP—epilepsy syndrome	4.86e-06	8.53e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—DUSP6—epilepsy syndrome	4.82e-06	8.46e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—S100B—epilepsy syndrome	4.75e-06	8.33e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PLAT—epilepsy syndrome	4.74e-06	8.32e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SOCS3—epilepsy syndrome	4.7e-06	8.25e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CDC42—epilepsy syndrome	4.69e-06	8.23e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—SRC—epilepsy syndrome	4.66e-06	8.18e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	4.63e-06	8.13e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	4.63e-06	8.13e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HES1—epilepsy syndrome	4.59e-06	8.06e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCL12—epilepsy syndrome	4.57e-06	8.02e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—BDKRB2—epilepsy syndrome	4.57e-06	8.02e-05	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—POMC—epilepsy syndrome	4.57e-06	8.01e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PRKCB—epilepsy syndrome	4.55e-06	7.99e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—VEGFA—epilepsy syndrome	4.54e-06	7.97e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AVP—epilepsy syndrome	4.54e-06	7.96e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL6ST—epilepsy syndrome	4.53e-06	7.96e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—JUNB—epilepsy syndrome	4.49e-06	7.88e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CNR1—epilepsy syndrome	4.49e-06	7.88e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PLCB1—epilepsy syndrome	4.47e-06	7.85e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FYN—epilepsy syndrome	4.47e-06	7.84e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—H2AFX—epilepsy syndrome	4.45e-06	7.81e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—HMOX1—epilepsy syndrome	4.45e-06	7.81e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MEF2C—epilepsy syndrome	4.44e-06	7.8e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CAT—epilepsy syndrome	4.39e-06	7.7e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HTR7—epilepsy syndrome	4.38e-06	7.68e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.31e-06	7.57e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—YWHAZ—epilepsy syndrome	4.3e-06	7.54e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HES1—epilepsy syndrome	4.29e-06	7.53e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—AGT—epilepsy syndrome	4.29e-06	7.52e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ABCB1—epilepsy syndrome	4.27e-06	7.49e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HBEGF—epilepsy syndrome	4.25e-06	7.46e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NGF—epilepsy syndrome	4.25e-06	7.45e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.23e-06	7.42e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—APOE—epilepsy syndrome	4.2e-06	7.37e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKT3—epilepsy syndrome	4.17e-06	7.32e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FYN—epilepsy syndrome	4.17e-06	7.32e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—H2AFX—epilepsy syndrome	4.16e-06	7.3e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MEF2C—epilepsy syndrome	4.15e-06	7.28e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—POMC—epilepsy syndrome	4.15e-06	7.28e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCR5—epilepsy syndrome	4.13e-06	7.25e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	4.08e-06	7.15e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	4.06e-06	7.12e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HTR2A—epilepsy syndrome	4.04e-06	7.09e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—YWHAZ—epilepsy syndrome	4.01e-06	7.04e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GPX1—epilepsy syndrome	3.97e-06	6.97e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NGF—epilepsy syndrome	3.97e-06	6.96e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCR5—epilepsy syndrome	3.86e-06	6.77e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	3.85e-06	6.76e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TSC2—epilepsy syndrome	3.84e-06	6.74e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AGT—epilepsy syndrome	3.84e-06	6.73e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—AKT1—epilepsy syndrome	3.82e-06	6.7e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	3.82e-06	6.7e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	3.81e-06	6.68e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	3.78e-06	6.63e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HTR2A—epilepsy syndrome	3.78e-06	6.63e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APOE—epilepsy syndrome	3.76e-06	6.6e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	3.69e-06	6.47e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KDR—epilepsy syndrome	3.68e-06	6.46e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	3.68e-06	6.46e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	3.66e-06	6.42e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.63e-06	6.37e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—POMC—epilepsy syndrome	3.61e-06	6.33e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TSC2—epilepsy syndrome	3.59e-06	6.3e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AGT—epilepsy syndrome	3.58e-06	6.29e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—AKT1—epilepsy syndrome	3.57e-06	6.26e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PRKCB—epilepsy syndrome	3.54e-06	6.22e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6ST—epilepsy syndrome	3.53e-06	6.19e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APOE—epilepsy syndrome	3.51e-06	6.16e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	3.49e-06	6.12e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AGT—epilepsy syndrome	3.48e-06	6.11e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KDR—epilepsy syndrome	3.44e-06	6.04e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—APOE—epilepsy syndrome	3.41e-06	5.98e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	3.39e-06	5.95e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	3.38e-06	5.93e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	3.37e-06	5.92e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PRKCB—epilepsy syndrome	3.31e-06	5.81e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.31e-06	5.81e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	3.3e-06	5.79e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6ST—epilepsy syndrome	3.3e-06	5.79e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ALB—epilepsy syndrome	3.29e-06	5.77e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	3.26e-06	5.72e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	3.23e-06	5.67e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	3.22e-06	5.65e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	3.16e-06	5.54e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	3.14e-06	5.51e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	3.13e-06	5.5e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	3.13e-06	5.49e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	3.07e-06	5.38e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	3.02e-06	5.29e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.99e-06	5.24e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.95e-06	5.18e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	2.95e-06	5.18e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—TH—epilepsy syndrome	2.94e-06	5.16e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—POMC—epilepsy syndrome	2.93e-06	5.14e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	2.91e-06	5.11e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	2.91e-06	5.11e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	2.9e-06	5.08e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.9e-06	5.08e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	2.88e-06	5.05e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	2.86e-06	5.01e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	2.85e-06	5e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	2.79e-06	4.9e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	2.69e-06	4.72e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	2.68e-06	4.7e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ALB—epilepsy syndrome	2.67e-06	4.69e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	2.67e-06	4.68e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	2.65e-06	4.65e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	2.6e-06	4.56e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	2.48e-06	4.34e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	2.46e-06	4.31e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	2.45e-06	4.3e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	2.43e-06	4.26e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CAT—epilepsy syndrome	2.42e-06	4.25e-05	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	2.41e-06	4.23e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	2.4e-06	4.21e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	2.39e-06	4.19e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	2.36e-06	4.14e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	2.34e-06	4.1e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	2.32e-06	4.07e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	2.26e-06	3.96e-05	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	2.25e-06	3.95e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	2.23e-06	3.92e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.19e-06	3.84e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	2.19e-06	3.84e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	2.17e-06	3.81e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	2.17e-06	3.8e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	2.11e-06	3.7e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	2.08e-06	3.65e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	2.05e-06	3.59e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	2.03e-06	3.56e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	2.01e-06	3.53e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	1.97e-06	3.46e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	1.95e-06	3.41e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.92e-06	3.37e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	1.9e-06	3.33e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.88e-06	3.3e-05	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.83e-06	3.21e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	1.81e-06	3.18e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	1.76e-06	3.09e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	1.71e-06	3.01e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.66e-06	2.92e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.62e-06	2.84e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	1.58e-06	2.77e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	1.54e-06	2.7e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.47e-06	2.59e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—AKT1—epilepsy syndrome	1.45e-06	2.54e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	1.29e-06	2.27e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.29e-06	2.26e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	1.21e-06	2.12e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	1.17e-06	2.06e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	9.82e-07	1.72e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	6.48e-07	1.14e-05	CbGpPWpGaD
